Not applicableUnknownNCT03687229What this trial is testingThe Effect Of DAAs on miRNA-122 And Insulin Resistance In Chronic HCV PatientsWho this might be right forChronic Hepatitis c Assiut University 60
Post-approval studies (Phase 4)Study completedNCT02734173What this trial is testingPilot HCV Direct Acting Antiviral Therapy and MetabolismWho this might be right forHepatitis C Ottawa Hospital Research Institute 24
Large-scale testing (Phase 3)Study completedNCT01701401What this trial is testingSafety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination (FDC) With and Without Ribavirin for the Treatment of HCVWho this might be right forChronic Hepatitis C Virus Gilead Sciences 870
Post-approval studies (Phase 4)Ended earlyNCT05717400What this trial is testingImproving Response to Immunotherapy in Patients With Advanced Hepatocellular Carcinoma and Chronic Hepatitis C Virus Infection With Direct-Acting Antiviral TherapyWho this might be right forLiver Cancer M.D. Anderson Cancer Center 2
Not applicableStudy completedNCT02758509What this trial is testingImpact of Antiviral Therapy on Gastroesophageal Varices.Who this might be right forChronic Hepatitis CCirrhosis Parc de Salut Mar 237
Large-scale testing (Phase 3)Study completedNCT01604850What this trial is testingSofosbuvir + Ribavirin for 12 or 16 Weeks in Treatment Experienced Subjects With Chronic Genotype 2 or 3 HCV Infection (FUSION)Who this might be right forChronic Hepatitis C Gilead Sciences 202
Testing effectiveness (Phase 2)Study completedNCT01434498What this trial is testingGS-5885, GS-9451, Tegobuvir and Ribavirin (RBV) in Interferon Ineligible or Intolerant Subjects With Chronic Genotype 1a or 1b Hepatitis C Virus (HCV) InfectionWho this might be right forChronic Genotype 1a or 1b HCV Infection Gilead Sciences 163
Not applicableUnknownNCT03775798What this trial is testingIncidence of de Novo Hepatocellular Carcinoma After Antiviral Agents for HCV.Who this might be right forHepatitis CCirrhosisAntiviral Drug Adverse Reaction Austral University, Argentina 2,200
Not applicableStudy completedNCT03602703What this trial is testingImmune Responses in Hepatocellular Carcinoma Patients After Treatment With Direct Acting Antiviral DrugsWho this might be right forDrug-Induced Liver Injury Assiut University 42
Not applicableUnknownNCT02904603What this trial is testingImmune Monitoring of Hepatitis C Under DAA TherapyWho this might be right forHepatitis C University of Regensburg 100
Testing effectiveness (Phase 2)Study completedNCT01441180What this trial is testingGS-7977 With Ribavirin for Hepatitis C (SPARE)Who this might be right forHepatitis C National Institute of Allergy and Infectious Diseases (NIAID) 60
Not applicableApproved For MarketingNCT01779518What this trial is testingExpanded Access Program of Sofosbuvir With Ribavirin and With or Without Pegylated Interferon in Aggressive Post-transplant Hepatitis CWho this might be right forPost-transplant Hepatitis C Gilead Sciences
Not applicableStudy completedNCT03902366What this trial is testingHCV and Co-morbid Alcohol Use Disorders: A Translational Investigation of Antiviral Therapy Outcomes on CNS FunctionWho this might be right forHepatitis CAlcohol Use Disorder VA Office of Research and Development 63
Not applicableUnknownNCT03551002What this trial is testingImpact of DAA Uptake in Controlling HCV Epidemic and Modeling Interventions for HCV Elimination Among HIV-infected Persons in San DiegoWho this might be right forHepatitis CHepatitis C, ChronicHIV/AIDS University of California, San Diego 450
Not applicableUnknownNCT05506475What this trial is testingEvaluation of HCV Care and Treatment for HIV-HCV Co-infected Patients in Decentralised Areas in VietnamWho this might be right forHIV InfectionHepatitis C Infection Institut Pasteur 400
Testing effectiveness (Phase 2)Study completedNCT02356562What this trial is testingOmbitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Sofosbuvir and Ribavirin in Direct-Acting Antiviral Agent Treatment-Experienced Adults With Chronic Hepatitis C Virus InfectionWho this might be right forChronic Hepatitis C Infection AbbVie 29
Testing effectiveness (Phase 2)Study completedNCT01435226What this trial is testingGS-5885, GS-9451, Tegobuvir and Ribovirin in Treatment-Experienced Subjects With Chronic Genotype 1a Or 1b Hepatitis C Virus (HCV) InfectionWho this might be right forHepatitis C, Chronic Gilead Sciences 170
Not applicableStudy completedNCT03283176What this trial is testingHematologic Profile, Vit. B12 and Folic Acid in Cirrhotics Received Sofosbuvir and Daclatasvir With or Without RibavirinWho this might be right forLiver CirrhosesChronic Hepatitis cDirectly Acting Antivirals Assiut University 50
Not applicableUnknownNCT04220151What this trial is testingEpigenetic Changes in Hepatocellular Carcinoma Developed After Direct Acting Antiviral Therapy for Chronic Hepatitis CWho this might be right forHepatocellular Carcinoma Assiut University 100
Large-scale testing (Phase 3)Study completedNCT01979939What this trial is testingUNITY 1: A Study of an Investigational Treatment Regimen of Daclatasvir (DCV) + Asunaprevir (ASV) + BMS-791325 in a Fixed Dose Combination (the DCV 3DAA (Direct Acting Antiviral) Regimen) for 12 Weeks for the Treatment of Chronic Hepatitis C Virus (HCV) Genotype 1 Infection in Non-cirrhotic SubjectsWho this might be right forHepatitis C Bristol-Myers Squibb 416